Tuesday, November 5, 2019

Sun Pharma inks licensing pact with AstraZeneca to introduce products in China

Sun Pharma inks licensing pact with AstraZeneca to introduce products in China This comes after AstraZeneca said it was launching a new fund with China International Capital Corp to invest $1 billion in China#39;s healthcare sector, as it expands its research work in the country.

from Moneycontrol Business News https://ift.tt/32mmuQ3
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Market moves driven more by psychology than fundamentals: Samir Arora

Indian stock markets are caught between global worries and strong domestic company profits. Foreign investor activity, oil price swings, and...